ArcBest Corporation (ARCB) Stock Forecast
Data as of May 3, 2026Industrials · Current price $125.81 (-1.38%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 4, 2026 | Thomas Wadewitz | UBS | $98.00 | -22.1% |
| Feb 2, 2026 | Bruce Chan | Stifel Nicolaus | $94.00 | -25.3% |
| Jan 31, 2026 | Jordan Alliger | Goldman Sachs | $100.00 | -20.5% |
| Jan 6, 2026 | Reed Seay | Stephens | $85.00 | -32.4% |
| Jul 31, 2025 | Bruce Chan | Stifel Nicolaus | $81.00 | -35.6% |
| Feb 3, 2025 | Ravi Shanker | Morgan Stanley | $145.00 | +15.3% |
| Oct 9, 2024 | Ariel Rosa | Citigroup | $111.00 | -11.8% |
| Aug 6, 2024 | Bruce Chan | Stifel Nicolaus | $131.00 | +4.1% |
| Jul 8, 2024 | Ravi Shanker | Morgan Stanley | $176.00 | +39.9% |
| May 14, 2024 | Bruce Chan | Stifel Nicolaus | $150.00 | +19.2% |
| May 1, 2024 | Thomas Wadewitz | UBS | $126.00 | +0.2% |
| Aug 1, 2023 | Bruce Chan | Stifel Nicolaus | $134.00 | +6.5% |
Top Analysts Covering ARCB
ARCB vs Sector & Market
| Metric | ARCB | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.44 | 2.41 | 2.41 |
| Analyst Count | 25 | 8 | 18 |
| Target Upside | -6.9% | +85.0% | +14.9% |
| P/E Ratio | 51.77 | 28.12 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.14B | $4.23B | $4.36B | 8 |
| 2027-03-31 | $1.03B | $1.06B | $1.08B | 3 |
| 2027-06-30 | $1.10B | $1.12B | $1.15B | 3 |
| 2027-09-30 | $1.13B | $1.16B | $1.19B | 3 |
| 2027-12-31 | $1.07B | $1.10B | $1.13B | 3 |
| 2028-03-31 | $1.01B | $1.04B | $1.07B | 2 |
| 2028-06-30 | $1.02B | $1.05B | $1.07B | 2 |
| 2028-09-30 | $1.03B | $1.05B | $1.08B | 2 |
| 2028-12-31 | $1.04B | $1.06B | $1.09B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.40 | $4.70 | $4.99 | 8 |
| 2027-03-31 | $0.72 | $0.75 | $0.77 | 3 |
| 2027-06-30 | $2.09 | $2.15 | $2.22 | 5 |
| 2027-09-30 | $2.33 | $2.40 | $2.48 | 3 |
| 2027-12-31 | $1.87 | $1.93 | $2.00 | 6 |
| 2028-03-31 | $0.79 | $0.82 | $0.85 | 4 |
| 2028-06-30 | $2.48 | $2.55 | $2.64 | 6 |
| 2028-09-30 | $2.69 | $2.78 | $2.87 | 4 |
| 2028-12-31 | $2.00 | $2.06 | $2.13 | 7 |
Frequently Asked Questions
What is the analyst consensus for ARCB?
The consensus among 25 analysts covering ArcBest Corporation (ARCB) is Buy with an average price target of $92.83.
What is the highest price target for ARCB?
The highest price target for ARCB is $176.00, set by Ravi Shanker at Morgan Stanley on 2024-07-08.
What is the lowest price target for ARCB?
The lowest price target for ARCB is $81.00, set by Bruce Chan at Stifel Nicolaus on 2025-07-31.
How many analysts cover ARCB?
25 analysts have issued ratings for ArcBest Corporation in the past 12 months.
Is ARCB a buy or sell right now?
Based on 25 analyst ratings, ARCB has a consensus rating of Buy (2.44/5) with a -6.9% upside to the consensus target of $92.83.
What are the earnings estimates for ARCB?
Analysts estimate ARCB will report EPS of $4.70 for the period ending 2026-12-31, with revenue estimated at $4.23B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.